EPTINEZUMAB RESULTS FOR THE PREVENTION OF EPISODIC MIGRAINE THROUGH 1 YEAR IN THE PHASE 3 PROMISE-1 (PREVENTION OF MIGRAINE VIA INTRAVENOUS EPTINEZUMAB SAFETY AND EFFICACY-1) TRIAL

Dodick, D; Janelidze, M; Saper, J; Kudrow, D; Chakhava, G; Schaeffler, B; Cady, R; Hirman, J; Smith, J

CEPHALALGIA, 2018; 38 (): 89